![Camille Bedrosian](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 5 M $ au 31/05/2026
Le Dr Camille L. Bedrosian, MD, est directrice indépendante de Rhythm Pharmaceuticals, Inc. et de Crinetics Pharmaceuticals, Inc. et Chief Medical Officer & Executive Vice President d'Ultragenyx Pharmaceutical, Inc. et membre de l'American Society of Clinical Oncology, de l'American Society of Hematology et de l'American Society of Nephrology. Elle est membre du conseil d'administration de Rhythm Pharmaceuticals, Inc. et de Crinetics Pharmaceuticals, Inc. Auparavant, le Dr Bedrosian a été employée comme médecin en chef et vice-présidente principale chez Alexion Pharmaceuticals, Inc. et comme médecin en chef et vice-présidente chez ARIAD Pharmaceuticals, Inc. et comme directrice principale de l'oncologie et de l'hématologie chez Genetics Institute, Inc. et comme membre de l'American Association for Cancer Research, de l'American Association for the Advancement of Science, du Duke Comprehensive Cancer Center et comme professeur adjoint au Duke University Medical Center. Elle a obtenu son diplôme de premier cycle à l'université de Harvard, un diplôme d'études supérieures au Massachusetts Institute of Technology et un doctorat à la Harvard Medical School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/04/2026 | 265 285 ( 0,24 % ) | 4 M $ | 31/05/2026 | |
| 24/06/2025 | 7 000 ( 0,01 % ) | 618 240 $ | 31/05/2026 | |
| 20/04/2026 | 9 400 ( 0,01 % ) | 334 170 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 03/09/2020 |
| AMYLYX PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 28/11/2023 |
American Society of Nephrology
 American Society of Nephrology Medical/Nursing ServicesHealth Services Engages in prevent, treat and cure kidney diseases | Corporate Officer/Principal | - |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Corporate Officer/Principal | 13/07/2009 |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | 13/07/2009 |
MIT Corp. (United States)
 MIT Corp. (United States) Other Consumer ServicesConsumer Services MIT Corp. (US) owns and operates as a trust. The corporation and its committees have responsibility for reviewing and providing guidance on strategic directions, approving annual budgets and exercising long-term fiduciary responsibility. The company was founded in 1861 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 16/12/2025 |
| ULTRAGENYX PHARMACEUTICAL INC. | Directeur Technique/Scientifique/R&D | 01/05/2023 |
| ALEXION PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2018 |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 18 |
|---|---|
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Rhythm Pharmaceuticals, Inc.
 Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
American Association for the Advancement of Science
 American Association for the Advancement of Science Miscellaneous Commercial ServicesCommercial Services Provides science related journal, program, and education services | Commercial Services |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Commercial Services |
American Society of Nephrology
American Society of Nephrology Medical/Nursing ServicesHealth Services Engages in prevent, treat and cure kidney diseases | Health Services |
Duke University Medical Center
 Duke University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke Comprehensive Cancer Center
 Duke Comprehensive Cancer Center Duke Comprehensive Cancer Center develops outpatient bone-marrow transplantation program. The company is headquartered in Durham, NC. | |
MIT Corp. (United States)
MIT Corp. (United States) Other Consumer ServicesConsumer Services MIT Corp. (US) owns and operates as a trust. The corporation and its committees have responsibility for reviewing and providing guidance on strategic directions, approving annual budgets and exercising long-term fiduciary responsibility. The company was founded in 1861 and is headquartered in Cambridge, MA. | Consumer Services |
Crinetics Pharmaceuticals, Inc.
 Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Amylyx Pharmaceuticals, Inc.
 Amylyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products to cure neurodegenerative diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
